Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
Phase 1/2 Terminated
53 enrolled 22 charts
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Phase 2 Terminated
90 enrolled 24 charts
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
Phase 1 Terminated
144 enrolled
Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
Phase 1 Terminated
2 enrolled
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Phase 1/2 Terminated
74 enrolled 23 charts
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
Phase 2 Terminated
15 enrolled 9 charts
FLAG
Phase 1 Terminated
3 enrolled
I-ATTAC
Phase 2 Terminated
6 enrolled 7 charts
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
Phase 1 Terminated
7 enrolled 12 charts
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Terminated
4 enrolled 6 charts
Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
Phase 1 Terminated
4 enrolled
FOLAGLI
Phase 1 Terminated
24 enrolled
329
Phase 1/2 Terminated
12 enrolled 13 charts
PERFORMANCE
Phase 1 Terminated
27 enrolled 13 charts
Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
Phase 2 Terminated
18 enrolled
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Phase 1/2 Terminated
21 enrolled 8 charts
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
Phase 1/2 Terminated
14 enrolled
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
Phase 2 Terminated
1 enrolled 8 charts
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
Phase NA Terminated
15 enrolled 6 charts
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Phase 2 Terminated
54 enrolled 10 charts
Toca5
Phase 2/3 Terminated
403 enrolled
Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
Phase 1 Terminated
1 enrolled
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Phase 1 Terminated
15 enrolled
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
Phase 2 Terminated
41 enrolled 9 charts
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Phase 1/2 Terminated
12 enrolled 12 charts
Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
Phase 1 Terminated
18 enrolled
Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Phase 1 Terminated
16 enrolled
Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients
Phase 2 Terminated
10 enrolled
FMISOPETSCS
Phase 2 Terminated
6 enrolled
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Terminated
10 enrolled
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
Phase 2 Terminated
15 enrolled
Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma
Phase 1 Terminated
30 enrolled
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
Phase 1 Terminated
1 enrolled
IDEPREG
Terminated
16 enrolled
STRONG
Phase NA Terminated
4 enrolled 8 charts
O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
Phase 2 Terminated
12 enrolled 10 charts
Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
Phase 2 Terminated
1 enrolled 3 charts
HGG-CilMetro
Phase 2 Terminated
28 enrolled
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
Phase 1 Terminated
14 enrolled
Glass-Art
Phase 3 Terminated
9 enrolled
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Terminated
8 enrolled
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Terminated
3 enrolled
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
Phase 2 Terminated
40 enrolled
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
Phase 2 Terminated
1 enrolled